Virbac: raises annual targets
(CercleFinance.com) - Coinciding with the resignation of its CEO, Virbac has announced that it is raising its targets for 2024, aiming for sales growth at constant exchange rates of between 12.
5% and 14.5% (organic growth now expected to be between 7% and 9%).
In addition, its ratio of adjusted operating profit to sales should consolidate at around 16% at constant exchange rates and scope of consolidation. On an actual basis, the impact of the Sasaeah and Globion acquisitions should be slightly accretive to this ratio.
The animal health group justifies these increases by sales growth expected to be around 16% at constant exchange rates (around 11% organic) in H1, with strong sales momentum expected to continue in H2.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
5% and 14.5% (organic growth now expected to be between 7% and 9%).
In addition, its ratio of adjusted operating profit to sales should consolidate at around 16% at constant exchange rates and scope of consolidation. On an actual basis, the impact of the Sasaeah and Globion acquisitions should be slightly accretive to this ratio.
The animal health group justifies these increases by sales growth expected to be around 16% at constant exchange rates (around 11% organic) in H1, with strong sales momentum expected to continue in H2.
Copyright (c) 2024 CercleFinance.com. All rights reserved.